Cellular immune response levels in gestational trophoblastic tumor patients after hydatidiform mole

被引:0
作者
Sutoto, MT [1 ]
机构
[1] Diponegoro Univ, Dept Obstet & Gynecol, Semarang, Indonesia
关键词
hydatidiform mole; gestational trophoblastic tumor;
D O I
10.1016/S0020-7292(99)00021-1
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study looked for an association of natural (innate) cellular immune responses with the development of gestational trophoblastic tumors (GTT) after hydatidiform moles (HM). Method: An observational prospective cohort study (73 patients) was carried out to measure the serum level of Natural Killer (NK) cells, Monocytes (Mo) and a Bio-Merieux skin test was performed on the day of HM evacuation and 4 weeks afterwards. The diagnosis of GTT were after Soper and Hammond (1998) and followed up for at least 6 months after evacuation. Patients' characteristics and cellular immune responses among patients who developed GTT were analysed by multiple logistic regression (SPSS version 5). Results: The results showed that a low NK cell percentage was associated (P = 0.020) with the development of GTT, also a low Mo (P = 0.034) on day 0. While on day 28 a low NK cell percentage (P = 0.008) and Mo cell count (P = 0.043) were associated with the development of GTT. The cut-off point between the sensitivity (60%) and specificity of NK cell percentage on day 0 was 16, and also showed a negative predictive value of 83%. Meanwhile on day 28, the cut-off point between the sensitivity and specificity (80%) was 17, and showed a negative predictive value of NK cell percentage (85%). Conclusion: These figures indicated that HM-lowered NK cell serum percentages were associated with the development of GTT. (C) 1999 International Federation of Gynecology and Obstetrics.
引用
收藏
页码:273 / 279
页数:7
相关论文
共 10 条
[1]  
BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO
[2]  
2-E
[3]  
DENT J, 1986, TROPHOBLASTIC DIS, P129
[4]  
FULLER AF, 1977, CLIN OBSTET GYNECOL, P681
[5]  
Iaffaioli R. V., 1993, European Journal of Gynaecological Oncology, V14, P412
[6]  
LAVIN PT, 1993, PRACTICAL GYNECOLOGI, P150
[7]  
LEMESHAW S, 1990, ADEQUACY SAMPLE SIZE, P129
[8]  
LIVINGSTON P, 1993, ANN NY ACAD SCI, V690, P1
[9]  
SOPER JT, 1988, OBSTET GYN CLIN N AM, V15, P505
[10]  
SUGAWA T, 1986, TROPHOBLASTIC DIS, P41